Cannabinoid Hyperemesis Syndrome
JAMA · 10.11.2026 · 336 (18) · 1642
DOI: 10.1001/jama.2026.7873 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 10.11.2026. Verfasst von Thangam Venkatesan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University, Columbus. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
This JAMA Insights discusses cannabinoid hyperemesis syndrome, including pathophysiology, clinical presentation, and the epidemiology and risk factors.
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University, Columbus.
- Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Scottsdale.
- Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic Minnesota, Rochester.
Zitieren
APA
Venkatesan, T., Hasler, W. L., & Camilleri, M. (2026). Cannabinoid Hyperemesis Syndrome. JAMA, 336(18), 1642. https://doi.org/10.1001/jama.2026.7873
Vancouver
Venkatesan T, Hasler WL, Camilleri M. Cannabinoid Hyperemesis Syndrome. JAMA. 2026;336(18):1642. doi:10.1001/jama.2026.7873
BibTeX
@article{Venkatesan2026,
author = {Venkatesan, Thangam and Hasler, William L and Camilleri, Michael},
title = {Cannabinoid Hyperemesis Syndrome},
journal = {JAMA},
year = {2026},
volume = {336},
number = {18},
pages = {1642},
doi = {10.1001/jama.2026.7873}
}
EUVIMED